Click here for slides on this topic


An investigational combination of the GLP-1 receptor agonist, lixisenatide, and long-acting insulin glargine.
The following content matched the glossary term: LixiLan

ADA 2015: The 75th Scientific Sessions of the American Diabetes Association


Coverage of data from ADA 2015, June 5-9, 2015 in Boston, Massachusetts

Slide Library Results

Search Results for: LixiLan Slides Found: 0